Generate Biomedicines

Biotech

generatebiomedicines.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
40
3 granted · 37 pending
Sector median: 2

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1613DIVERSE BIOTECH, INC.—$669K
1614XORTX Therapeutics Inc.—$505K
1615Stratum Biosciences Inc.—$100K
1616Generate Biomedicines——
1617Provizigen LLC——
1618ALZHEON, INC.—$134M
1619Repair Biotechnologies, Inc.—$25M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 3 granted of 40
  • Diffusion Model For Generative Protein Designapplication
  • Image Generation With Flexible Sampler For Diffusion Modelingapplication
  • ANTI-IL-13 Antibodies And Methods Of Use Thereofapplication
  • Image Generation With Flexible Sampler For Diffusion Modelinggranted
  • Diffusion Model For Generative Protein Designgranted
  • Diffusion Model For Generative Protein Designapplication
  • Antigen Binding Molecules Targeting SARS-CoV-2application
  • Antigen Binding Molecules Targeting SARS-CoV-2granted
  • Diffusion Model For Generative Protein Designapplication
  • Antigen Binding Molecules Targeting SARS-CoV-2application
  • Methods Of Treating Or Preventing Sarbecovirus With Antibodies Or Antigen-binding Fragments Thereofapplication
  • Methods Of Treating Or Preventing Sarbecovirus With Antibodies Or Antigen-binding Fragments Thereofapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.